CRC Risk Down With ACEi, Angiotensin Receptor Blocker Use

MONDAY, July 6, 2020 -- The use of angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers is associated with lower risk of colorectal cancer risk that develops within three years after index colonoscopy, according to a...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news